Repairing & Restoring Cellular Health
C15:0 works at the cellular level to reverse key hallmarks of aging, while reducing clinically-relevant drivers of chronic disease.

The essentiality of C15:0 is borne from numerous cellular benefits
C15:0 is a pleiotropic nutrient, which means that it acts in multiple ways to provide broad physical and mental health benefits. Specifically, C15:0 works by naturally targeting key receptors, reversing hallmarks of aging, lowering drivers of chronic disease, and making a beneficial metabolite. Please Note: All peer-reviewed studies demonstrating the active benefits of C15:0 used pure, free fatty acid C15:0 powder at appropriate concentrations. These benefits are not expected from products that combine C15:0 with oils or competing proinflammatory fatty acids.

Targeted Receptors
By naturally targeting receptors throughout out bodies, C15:0 has been shown to:
- Activate the AMPK pathway which maintains cellular homeostasis, regulates glucose metabolism, and is a core component of the human longevity pathway.
- Activate PPAR alpha-delta receptors that regulate metabolism, immunity, mood, appetite, and sleep.
- Inhibit HDAC-6, which reduces cancer cell proliferation.
- Inhibit MAPK and JAK-STAT signaling, which reduces inflammation.
Selected References
- Ediriweera, M.K. et al. Odd-chain fatty acids as novel histone deacetylase 6 (HDAC6) inhibitors. Biochimie 186:147-156 (2021).
- Fu, W.C. et al. Pentadecanoic acid promotes basal and insulin-stimulated glucose uptake in C2C12 myotubes. Food Nutr Res 65:10.29219/fnr.v65.4527 (2021).
- To, N.B., Nguyen, Y.T., Moon, J.Y., Ediriweera, M.K., Cho, S.K. Pentadecanoic acid, an odd-chain fatty acid, suppresses the stemness of MCF-7/SC human breast cancer stem-like cells through JAK2/STAT3 signaling. Nutrients 12:1663 (2020).
- Venn-Watson, S., Lumpkin, R., Dennis, E.A. Efficacy of dietary odd-chain saturated fatty acid pentadecanoic acid parallels broad associated health benefits in humans: could it be essential? Sci Rep 10:8161 (2020).
Download or Share
Close
Reversed Hallmarks of Aging
C15:0 reverses multiple drivers of aging and has been shown to:
- Improve cellular resilience against premature breakdown.
- Decrease reactive oxygen species and lipid peroxidation.
- Repair mitochondrial function and increase ATP production.
- Improve cellular signaling.
- Slow a key biomarker of aging rate (i.e. raise hemoglobin).
Selected References
- Adachi, K., Yokoyama, D., Tamai, H., Sadai, M., Oba, K. Effect of the glyceride of pentadecanoic acid on energy metabolism in hair follicles. Int J Cosmetic Sci 15, 125-131 (1993).
- Ediriweera, M.K. et al. Odd-chain fatty acids as novel histone deacetylase 6 (HDAC6) inhibitors. Biochimie 186:147-156 (2021).
- Pfeuffer, M. and Jaudszus, A. Pentadecanoic and heptadecanoic acids: multifaceted odd-chain fatty acids. Adv Nutr 7, 730-734 (2016).
- Soboleva, M.K., Sharapov, V.I., Grek, O.R. Fatty acids of the lipid fraction of erythrocyte membranes and intensity of lipid peroxidation in iron deficiency. Bull Exp Biol Med 117, 600-602 (1994).
- Venn-Watson, S., Lumpkin, R., Dennis, E.A. Efficacy of dietary odd-chain saturated fatty acid pentadecanoic acid parallels broad associated health benefits in humans: could it be essential? Sci Rep 10:8161 (2020).
Download or Share
Close
Lowered Drivers of Chronic Disease
C15:0 has been shown to lower clinically-relevant biomarkers of chronic disease, including:
- Lower proinflammatory cytokines, including IL-6, MCP-1, VCAM-1, and PAI-1.
- Decrease proliferation of cancer cells.
- Decrease proliferation of fibroblasts to help slow or stop tissue fibrosis.
- Increase glucose uptake by cells.
- Treat multiple human cell disease systems mimicking inflammation, cardiovascular disease, liver cirrhosis, autoimmune disease, and allergies.
Selected References
- Fu, W.C. et al. Pentadecanoic acid promotes basal and insulin-stimulated glucose uptake in C2C12 myotubes. Food Nutr Res 65:10.29219/fnr.v65.4527 (2021).
- Li, Y. et al. Design, synthesis and antitumor activity study of a gemcitabine prodrug conjugated with a HDAC6 inhibitor. Bioorg Med Chem Letters 72:128881 (2022).
- To, N.B., Nguyen, Y.T., Moon, J.Y., Ediriweera, M.K., Cho, S.K. Pentadecanoic acid, an odd-chain fatty acid, suppresses the stemness of MCF-7/SC human breast cancer stem-like cells through JAK2/STAT3 signaling. Nutrients 12:1663 (2020).
- Venn-Watson, S., Lumpkin, R., Dennis, E.A. Efficacy of dietary odd-chain saturated fatty acid pentadecanoic acid parallels broad associated health benefits in humans: could it be essential? Sci Rep 10:8161 (2020).
- Venn-Watson, S.K., Butterworth, C.N. Broder and safer clinically-relevant activities of pentadecanoic acid compared to omega-3: Evaluation of an emerging essential fatty acid across twelve primary human cell-based disease systems. PLOS ONE https://doi.org/10.1371/journal.pone.0268778 (2022).
Download or Share
Close
Produced Active Metabolites
Our bodies use C15:0 to make a metabolite called pentadecanoylcarnitine (or PDC), which has been shown to:
- Activate CB1 and CB2 receptors that regulate mood, sleep, inflammation, and pain.
- Activate 5-HT1A and 5-HT1B receptors that help to lower stress.
- Inhibit H1 and H2 histamine receptors, which helps to treat allergy symptoms.
Selected References
- Venn-Watson, S., Reiner, J., Jensen, E.D. Pentadecanoylcarnitine is a newly discovered endocannabinoid with pleiotropic activities relevant to supporting physical and mental health.Scientific Reports 12:13717 (2022).
Download or Share
CloseWhole Body Health & Wellness
A strong body of science shows that C15:0 promotes cardiometabolic, immune and liver health, while a key C15:0 metabolite can support mental and cognitive health.
